ID: ALA5273586

Max Phase: Preclinical

Molecular Formula: C13H19N3O2

Molecular Weight: 249.31

Associated Items:

Representations

Canonical SMILES:  CCNC(=O)N1CCN(c2ccccc2O)CC1

Standard InChI:  InChI=1S/C13H19N3O2/c1-2-14-13(18)16-9-7-15(8-10-16)11-5-3-4-6-12(11)17/h3-6,17H,2,7-10H2,1H3,(H,14,18)

Standard InChI Key:  SFUNLUNLLGMENW-UHFFFAOYSA-N

Associated Targets(Human)

C-type lectin domain family 4 member M 115 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 249.31Molecular Weight (Monoisotopic): 249.1477AlogP: 1.24#Rotatable Bonds: 2
Polar Surface Area: 55.81Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.20CX Basic pKa: 2.33CX LogP: 1.10CX LogD: 1.10
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.83Np Likeness Score: -1.52

References

1. Sethi A, Sanam S, Alvala M..  (2021)  Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.,  222  [PMID:34146913] [10.1016/j.ejmech.2021.113561]

Source